Literature DB >> 8041369

Autosomal-dominant dentatorubropallidoluysian atrophy in the United Kingdom.

T T Warner1, G G Lennox, I Janota, A E Harding.   

Abstract

Dentatorubropallidoluysian atrophy (DRPLA) has been described chiefly in Japan and appears to be rare in Europe. It is of autosomal dominant inheritance. We report the first British family with DRPLA, which contains four affected individuals in two generations. The diagnosis was made at autopsy in one case. The age of onset of symptoms ranged from 15 to 38 years, and clinical features included ataxia, dementia, chorea, and dystonia; three patients had generalized seizures. The three living patients resemble those with early Huntington's disease clinically. Three main phenotypes of DRPLA have been proposed: an ataxo-choreoathetoid type, a pseudo-Huntington type, and a myoclonic epilepsy type. The variation in clinical presentation in our family demonstrates the difficulty in applying such classifications to this and other dominantly inherited disorders with phenotypic variation. DRPLA is likely to be confused with Huntington's disease in European families.

Entities:  

Mesh:

Year:  1994        PMID: 8041369     DOI: 10.1002/mds.870090302

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  A shared haplotype for dentatorubropallidoluysian atrophy (DRPLA) in Italian families testifies of the recent introduction of the mutation.

Authors:  Liana Veneziano; Elide Mantuano; Claudio Catalli; Cinzia Gellera; Alexandra Durr; Silvia Romano; Maria Spadaro; Marina Frontali; Andrea Novelletto
Journal:  J Hum Genet       Date:  2014-01-09       Impact factor: 3.172

2.  The relationship between (CAG)n repeat number and age of onset in a family with dentatorubral-pallidoluysian atrophy (DRPLA): diagnostic implications of confirmatory and predictive testing.

Authors:  N T Potter
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

3.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype.

Authors:  Y Robitaille; L Schut; S J Kish
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.